Celgene might buy CAR-T biotech Juno Therapeutics By: MarketWatch January 17, 2018 at 09:25 AM EST Juno is one of several companies pioneering a cancer treatment called CAR-T, which is new and very promising. Read More >> Related Stocks: Celgene Corp
